http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070018624-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 2005-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20070018624-A |
| titleOfInvention | Cinnamic aldehyde (ＣｉｎｎａｍａｌｄｅｈＹｄｅ) and 2-hydroxy cinnamic aldehyde (2'-Hｙｄｒｏｘｙｌ-ＣｉｎａａａｄｅｈＹｄｅ) as an active ingredient, a composition for treating and preventing obesity and a method for purifying the active ingredient |
| abstract | The present invention provides a pharmaceutical or food product containing one or two components selected from cinnamomum (CA) and 2-hydroxy cinnamic aldehyde (2'-Hydroxyl-cinnamaldehyde; HCA) isolated from Cinnamomum cassia. Regarding the pharmaceutical composition, CA and HCA can be usefully used for the treatment of obesity by effectively inhibiting the activity of matrix degraded metalloproteinases (MMPs), which play an important role in the growth of obesity and mast cells.n n n n Cinnamic aldehyde, metalloproteinase, obesity prevention and treatment |
| priorityDate | 2005-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.